Keyphrases
Inflammation
100%
Lipids
100%
Blood Pressure
100%
Sitagliptin
100%
Type 2 Diabetes Mellitus Patients
100%
Glibenclamide
100%
Arterial Stiffness
100%
Body Mass Index
36%
High-sensitivity C-reactive Protein (hs-CRP)
27%
Oxidative Stress
18%
Triglyceride Level
18%
Metformin
18%
8-isoprostane
18%
Patient-completed
9%
Glycated Hemoglobin
9%
Washout Period
9%
Stress Sensitivity
9%
Triglycerides
9%
Beneficial Effects
9%
Fasting Plasma Glucose
9%
24-h Ambulatory Blood Pressure Monitoring
9%
Type 2 Diabetic Patients
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Lipid Profile
9%
Inflammatory Activity
9%
Waist Circumference
9%
Hypoglycemic Events
9%
Low-density Lipoprotein
9%
Index Level
9%
Diabetes Patients
9%
Glucose-lowering Drugs
9%
Blood Pressure Monitoring
9%
Oxidative Stress Status
9%
Weight Neutral
9%
Medicine and Dentistry
Blood Pressure
100%
Maturity Onset Diabetes of the Young
100%
Arterial Stiffness
100%
Glibenclamide
100%
Sitagliptin
100%
Body Mass Index
36%
Triacylglycerol
27%
Oxidative Stress
27%
C Reactive Protein
27%
Blood Pressure Monitoring
18%
Glycon
18%
8 Isoprostane
18%
Glycated Hemoglobin
9%
Diabetes
9%
Antidiabetic Agent
9%
High-Density Lipoprotein
9%
Low-Density Lipoprotein
9%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Blood Pressure
100%
Arterial Stiffness
100%
Glibenclamide
100%
Body Mass
36%
Oxidative Stress
27%
C-Reactive Protein
27%
Triacylglycerol Level
18%
Isoprostane
18%
Triglyceride
9%
Lipid Profile
9%
Glycated Hemoglobin
9%
Waist Circumference
9%
High-Density Lipoprotein
9%
Low-Density Lipoprotein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Sitagliptin
100%
Glibenclamide
100%
Non Insulin Dependent Diabetes Mellitus
100%
Triacylglycerol
27%
C Reactive Protein
27%
Metformin
18%
8 Isoprostane
18%
Glycosylated Hemoglobin
9%
Antidiabetic Agent
9%
High Density Lipoprotein
9%
Low Density Lipoprotein
9%